Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism

The protective effect of cruciferae-derived sulforaphane (SFN) on diabetic cardiomyopathy (DCM) has garnered increasing attention. However, no studies have specifically explored its mechanistic involvement in cardiac substrate metabolism and mitochondrial function. To address this gap, Type 2 diabet...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Pan Wang, Ziling Wang, Xinyuan Jin, Mengdi Zhang, Mengfan Shen, Dan Li
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-05-01
Serie:	Antioxidants
Soggetti:	sulforaphane cruciferae diabetic cardiomyopathy diabetes mellitus lipotoxicity substrate metabolism
Accesso online:	https://www.mdpi.com/2076-3921/14/5/603
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!